Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2012

Open Access 01-12-2012 | Research article

Reducing power and iron chelating property of Terminalia chebula (Retz.) alleviates iron induced liver toxicity in mice

Authors: Rhitajit Sarkar, Bibhabasu Hazra, Nripendranath Mandal

Published in: BMC Complementary Medicine and Therapies | Issue 1/2012

Login to get access

Abstract

Background

The 70% methanol extract of Terminalia chebula Retz. fruit (TCME) was investigated for its in vitro iron chelating property and in vivo ameliorating effect on hepatic injury of iron overloaded mice.

Methods

The effect of fruit extract on Fe2+-ferrozine complex formation and Fe2+ mediated pUC-18 DNA breakdown was studied in order to find the in vitro iron chelating activity. Thirty-six Swiss Albino mice were divided into six groups of: blank, patient control and treated with 50, 100, 200 mg/kg b.w. of TCME and desirox (standard iron chelator drug with Deferasirox as parent compound). Evaluations were made for serum markers of hepatic damage, antioxidant enzyme, lipid per oxidation and liver fibrosis levels. The reductive release of ferritin iron by the extract was further studied.

Results

In vitro results showed considerable iron chelation with IC50 of 27.19 ± 2.80 μg/ml, and a significant DNA protection with [P]50 of 1.07 ± 0.03 μg/ml along with about 86% retention of supercoiled DNA. Iron-dextran injection (i.p.) caused significant increase in the levels of the serum enzymes, viz., alanine aminotransferase (ALAT), aspartate aminotransferase (ASAT), alkaline phosphatase (ALP) and Bilirubin, which were subsequently lowered by oral administration of 200 mg/kg b.w. dose of the fruit extract by 81.5%, 105.88%, 188.08% and 128.31%, respectively. Similarly, treatment with the same dose of the extract was shown to alleviate the reduced levels of liver antioxidant enzyme superoxide dismutase, catalase, glutathione S-transferase and non-enzymatic reduced glutathione, by 49.8%, 53.5%, 35.4% and 11% respectively, in comparison to the iron overloaded mice. At the same time, the fruit extract effectively lowered the iron-overload induced raised levels of lipid per oxidation, protein carbonyl, hydroxyproline and liver iron by 49%, 67%, 67% and 26%, respectively, with oral treatment of 200 mg/kg b.w. dose of TCME. The fruit extract also showed potential activity for reductive release of ferritin iron.

Conclusions

These findings suggest that Terminalia chebula extract may contain active substances capable of lessening iron overload induced toxicity, and hence possibly be useful as iron chelating drug for iron overload diseases.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pulla Reddy AC, Lokesh BR: Effect of curcumin and eugenol on iron-induced hepatic toxicity in rats. Toxicol. 1996, 107: 39-45. 10.1016/0300-483X(95)03199-P.CrossRef Pulla Reddy AC, Lokesh BR: Effect of curcumin and eugenol on iron-induced hepatic toxicity in rats. Toxicol. 1996, 107: 39-45. 10.1016/0300-483X(95)03199-P.CrossRef
2.
go back to reference Kruszewski M: Labile iron pool: the main determinant of cellular response to oxidative stress. Mutat Res. 2003, 531: 81-92. 10.1016/j.mrfmmm.2003.08.004.CrossRefPubMed Kruszewski M: Labile iron pool: the main determinant of cellular response to oxidative stress. Mutat Res. 2003, 531: 81-92. 10.1016/j.mrfmmm.2003.08.004.CrossRefPubMed
3.
go back to reference Goodman LS, Gilman A: The Pharmacological Basis of Therapeutics. 2006, McGraw-Hill: New York, 11 Goodman LS, Gilman A: The Pharmacological Basis of Therapeutics. 2006, McGraw-Hill: New York, 11
4.
go back to reference Liu ZD, Hider RC: Design of iron chelators with therapeutic application. Coord Chem Rev. 2002, 232: 151-171. 10.1016/S0010-8545(02)00050-4.CrossRef Liu ZD, Hider RC: Design of iron chelators with therapeutic application. Coord Chem Rev. 2002, 232: 151-171. 10.1016/S0010-8545(02)00050-4.CrossRef
5.
go back to reference Birch N, Wang X, Chong HS: Iron chelators as therapeutic iron depletion agents. Expert Opin Ther Patents. 2006, 16: 1533-1556. 10.1517/13543776.16.11.1533.CrossRef Birch N, Wang X, Chong HS: Iron chelators as therapeutic iron depletion agents. Expert Opin Ther Patents. 2006, 16: 1533-1556. 10.1517/13543776.16.11.1533.CrossRef
6.
go back to reference Kapoor LD: Handbook of ayurvedic medicinal plants. Edited by: Boca R. 2001, CRC Press, 5 Kapoor LD: Handbook of ayurvedic medicinal plants. Edited by: Boca R. 2001, CRC Press, 5
7.
go back to reference Lee HS, Won NH, Kim KH, Lee H, Jun W, Lee KW: Antioxidant effects of aqueous extract of Terminalia chebula in vivo and in vitro. Biol Pharm Bull. 2005, 28: 1639-1644. 10.1248/bpb.28.1639.CrossRefPubMed Lee HS, Won NH, Kim KH, Lee H, Jun W, Lee KW: Antioxidant effects of aqueous extract of Terminalia chebula in vivo and in vitro. Biol Pharm Bull. 2005, 28: 1639-1644. 10.1248/bpb.28.1639.CrossRefPubMed
8.
go back to reference Naik GH, Priyadarsini KI, Bhagirathi RG, Mishra B, Mishra KP, Banavalikar MM, Mohan H: In vitro antioxidant studies and free radical reactions of triphala, an ayurvedic formulation and its constituents. Phytother Res. 2005, 19: 582-586. 10.1002/ptr.1515.CrossRefPubMed Naik GH, Priyadarsini KI, Bhagirathi RG, Mishra B, Mishra KP, Banavalikar MM, Mohan H: In vitro antioxidant studies and free radical reactions of triphala, an ayurvedic formulation and its constituents. Phytother Res. 2005, 19: 582-586. 10.1002/ptr.1515.CrossRefPubMed
9.
go back to reference Cheng HY, Lin TC, Yu KH, Yang CM, Lin CC: Antioxidant and free radical scavenging activities of Terminalia chebula. Biol Pharm Bull. 2003, 26: 1331-1335. 10.1248/bpb.26.1331.CrossRefPubMed Cheng HY, Lin TC, Yu KH, Yang CM, Lin CC: Antioxidant and free radical scavenging activities of Terminalia chebula. Biol Pharm Bull. 2003, 26: 1331-1335. 10.1248/bpb.26.1331.CrossRefPubMed
10.
go back to reference Mahesh R, Bhuvana S, Begum VMH: Effect of Terminalia chebula aqueous extract on oxidative stress and antioxidant status in the liver and kidney of young and aged rats. Cell Biochem Funct. 2009, 27: 358-363. 10.1002/cbf.1581.CrossRefPubMed Mahesh R, Bhuvana S, Begum VMH: Effect of Terminalia chebula aqueous extract on oxidative stress and antioxidant status in the liver and kidney of young and aged rats. Cell Biochem Funct. 2009, 27: 358-363. 10.1002/cbf.1581.CrossRefPubMed
11.
go back to reference Chang CL, Lin CS: Phytochemical Composition, Antioxidant Activity, and Neuroprotective Effect of Terminalia chebula Retzius Extracts. Evid Based Complement Altern Med. 2011, 2012: 10.1155/2012/125247. Chang CL, Lin CS: Phytochemical Composition, Antioxidant Activity, and Neuroprotective Effect of Terminalia chebula Retzius Extracts. Evid Based Complement Altern Med. 2011, 2012: 10.1155/2012/125247.
12.
go back to reference Saleem A, Husheem M, Harkonen P, Pihlaja K: Inhbition of cancer cell growth by crude extract and the phenolics of Terminalia chebula Retz. fruit. J Ethnopharmacol. 2002, 81: 327-336. 10.1016/S0378-8741(02)00099-5.CrossRefPubMed Saleem A, Husheem M, Harkonen P, Pihlaja K: Inhbition of cancer cell growth by crude extract and the phenolics of Terminalia chebula Retz. fruit. J Ethnopharmacol. 2002, 81: 327-336. 10.1016/S0378-8741(02)00099-5.CrossRefPubMed
13.
go back to reference Reddy DB, Reddy TC, Jyotsna G, Sharan S, Priya N, Lakshmipathi V, Reddanna P: Chebulagic acid, a COX-LOX dual inhibitor isolated from the fruits of Terminalia chebula Retz. induces apoptosis in COLO-205 cell line. J Ethnopharmacol. 2009, 124: 506-512. 10.1016/j.jep.2009.05.022.CrossRefPubMed Reddy DB, Reddy TC, Jyotsna G, Sharan S, Priya N, Lakshmipathi V, Reddanna P: Chebulagic acid, a COX-LOX dual inhibitor isolated from the fruits of Terminalia chebula Retz. induces apoptosis in COLO-205 cell line. J Ethnopharmacol. 2009, 124: 506-512. 10.1016/j.jep.2009.05.022.CrossRefPubMed
14.
go back to reference Das ND, Jung KH, Park JH, Mondol MAM, Shin HJ, Lee HS, Park KS, Choi MR, Kim KS, Kim MS, Lee SR, Chai YG: Terminalia chebula Extract Acts as a Potential NF‐κB Inhibitor in Human Lymphoblastic T Cells. Phytother Res. 2011, 25: 927-934. 10.1002/ptr.3398.CrossRefPubMed Das ND, Jung KH, Park JH, Mondol MAM, Shin HJ, Lee HS, Park KS, Choi MR, Kim KS, Kim MS, Lee SR, Chai YG: Terminalia chebula Extract Acts as a Potential NF‐κB Inhibitor in Human Lymphoblastic T Cells. Phytother Res. 2011, 25: 927-934. 10.1002/ptr.3398.CrossRefPubMed
15.
go back to reference Na M, Bae K, Kang SS, Min BS, Yoo JK, Kamiryo Y, Senoo Y, Yokoo S, Miwa N: Cytoprotective effect on oxidative stress and inhibitory effect on cellular aging of Terminalia chebula fruit. Phytother Res. 2004, 18: 737-741. 10.1002/ptr.1529.CrossRefPubMed Na M, Bae K, Kang SS, Min BS, Yoo JK, Kamiryo Y, Senoo Y, Yokoo S, Miwa N: Cytoprotective effect on oxidative stress and inhibitory effect on cellular aging of Terminalia chebula fruit. Phytother Res. 2004, 18: 737-741. 10.1002/ptr.1529.CrossRefPubMed
16.
go back to reference Rao NK, Nammi S: Antidiabetic and renoprotective effects of the chloroform extract of Terminalia chebula Retz. seeds in streptozotocin-induced diabetic rats. BMC Complement Altern Med. 2006, 6: 17-10.1186/1472-6882-6-17.CrossRefPubMedPubMedCentral Rao NK, Nammi S: Antidiabetic and renoprotective effects of the chloroform extract of Terminalia chebula Retz. seeds in streptozotocin-induced diabetic rats. BMC Complement Altern Med. 2006, 6: 17-10.1186/1472-6882-6-17.CrossRefPubMedPubMedCentral
17.
go back to reference Kim JH, Hong CO, Koo YC, Kim SJ, Lee KW: Oral Administration of Ethyl Acetate-Soluble Portion of Terminalia chebula Conferring Protection from Streptozotocin-Induced Diabetic Mellitus and Its Complications. Biol Pharm Bull. 2011, 34: 1702-1709. 10.1248/bpb.34.1702.CrossRefPubMed Kim JH, Hong CO, Koo YC, Kim SJ, Lee KW: Oral Administration of Ethyl Acetate-Soluble Portion of Terminalia chebula Conferring Protection from Streptozotocin-Induced Diabetic Mellitus and Its Complications. Biol Pharm Bull. 2011, 34: 1702-1709. 10.1248/bpb.34.1702.CrossRefPubMed
18.
go back to reference Malekzadeh F, Ehsanifar H, Shahamat M, Levin M, Colwell RR: Antibacterial activity of black myrobalan (Terminalia chebula Retz.) against Helicobacter pylori. Int J Antimicrob Agents. 2001, 18: 85-88. 10.1016/S0924-8579(01)00352-1.CrossRefPubMed Malekzadeh F, Ehsanifar H, Shahamat M, Levin M, Colwell RR: Antibacterial activity of black myrobalan (Terminalia chebula Retz.) against Helicobacter pylori. Int J Antimicrob Agents. 2001, 18: 85-88. 10.1016/S0924-8579(01)00352-1.CrossRefPubMed
19.
go back to reference Sharma P, Prakash T, Kotresha D, Ansari MA, Sahrm UR, Kumar B, Debnath J, Goli D: Antiulcerogenic activity of Terminalia chebula fruit in experimentally induced ulcer in rats. Pharm Biol. 2011, 49: 262-268. 10.3109/13880209.2010.503709.CrossRefPubMed Sharma P, Prakash T, Kotresha D, Ansari MA, Sahrm UR, Kumar B, Debnath J, Goli D: Antiulcerogenic activity of Terminalia chebula fruit in experimentally induced ulcer in rats. Pharm Biol. 2011, 49: 262-268. 10.3109/13880209.2010.503709.CrossRefPubMed
20.
go back to reference Gopi KS, Gopala Reddy A, Jyothi K, Anil Kumar B: Acetaminophen-induced Hepato- and Nephrotoxicity and Amelioration by Silymarin and Terminalia chebula in Rats. Toxicol International. 2010, 17: 64-66. 10.4103/0971-6580.72672.CrossRef Gopi KS, Gopala Reddy A, Jyothi K, Anil Kumar B: Acetaminophen-induced Hepato- and Nephrotoxicity and Amelioration by Silymarin and Terminalia chebula in Rats. Toxicol International. 2010, 17: 64-66. 10.4103/0971-6580.72672.CrossRef
21.
go back to reference Grover IS, Bala S: Antimutagenic activity of T. chebula (myroblan) in Salmonella typhimurium. Ind J Exp Biol. 1992, 30 (4): 339-341. Grover IS, Bala S: Antimutagenic activity of T. chebula (myroblan) in Salmonella typhimurium. Ind J Exp Biol. 1992, 30 (4): 339-341.
22.
go back to reference Cook NC, Samman S: Flavonoids-chemistry, metabolism, cardioprotective effects, and dietary sources. J Nutr Biochem. 1996, 7: 66-76. 10.1016/0955-2863(95)00168-9.CrossRef Cook NC, Samman S: Flavonoids-chemistry, metabolism, cardioprotective effects, and dietary sources. J Nutr Biochem. 1996, 7: 66-76. 10.1016/0955-2863(95)00168-9.CrossRef
23.
go back to reference Hazra B, Sarkar R, Biswas S, Mandal N: Comparative study of the antioxidant and reactive oxygen species scavenging properties in the extracts of the fruits of Terminalia chebula, Terminalia belerica and Emblica officinalis. BMC Complement Altern Med. 2010, 10: 20-10.1186/1472-6882-10-20.CrossRefPubMedPubMedCentral Hazra B, Sarkar R, Biswas S, Mandal N: Comparative study of the antioxidant and reactive oxygen species scavenging properties in the extracts of the fruits of Terminalia chebula, Terminalia belerica and Emblica officinalis. BMC Complement Altern Med. 2010, 10: 20-10.1186/1472-6882-10-20.CrossRefPubMedPubMedCentral
24.
go back to reference Bridges KR, Hoffman KE: The effects of ascorbic acid on the intracellular metabolism of iron and ferritin. J Biol Chem. 1986, 261: 14273-14277.PubMed Bridges KR, Hoffman KE: The effects of ascorbic acid on the intracellular metabolism of iron and ferritin. J Biol Chem. 1986, 261: 14273-14277.PubMed
25.
go back to reference Haro-Vicente JF, Martínez-Graciá C, Ros G: Optimisation of in vitro measurement of available iron from different fortificants in citric fruit juices. Food Chem. 2006, 98: 639-648. 10.1016/j.foodchem.2005.06.040.CrossRef Haro-Vicente JF, Martínez-Graciá C, Ros G: Optimisation of in vitro measurement of available iron from different fortificants in citric fruit juices. Food Chem. 2006, 98: 639-648. 10.1016/j.foodchem.2005.06.040.CrossRef
26.
go back to reference Hermes-Lima M, Nagy E, Ponka P, Schulman HM: The iron chelator pyridoxal isonicotinoyl hydrazone (PIH) protects plasmid pUC-18 DNA against .OH mediated strand breaks. Free Radical Bio Med. 1998, 25: 875-880. 10.1016/S0891-5849(98)00117-8.CrossRef Hermes-Lima M, Nagy E, Ponka P, Schulman HM: The iron chelator pyridoxal isonicotinoyl hydrazone (PIH) protects plasmid pUC-18 DNA against .OH mediated strand breaks. Free Radical Bio Med. 1998, 25: 875-880. 10.1016/S0891-5849(98)00117-8.CrossRef
27.
go back to reference Lowry OH, Roesborough MJ, Farr AL, Randall RJ: Protein measurement with Folin-Phenol reagent. J Biol Chem. 1951, 193: 265-275.PubMed Lowry OH, Roesborough MJ, Farr AL, Randall RJ: Protein measurement with Folin-Phenol reagent. J Biol Chem. 1951, 193: 265-275.PubMed
28.
go back to reference Kakkar P, Das B, Viswanathan PN: A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys. 1984, 21: 130-132.PubMed Kakkar P, Das B, Viswanathan PN: A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys. 1984, 21: 130-132.PubMed
29.
go back to reference Bonaventura J, Schroeder WA, Fang S: Human erythrocyte catalase: an improved method of isolation and a re-evaluation of reported properties. Arch Biochem Biophys. 1972, 150: 606-617. 10.1016/0003-9861(72)90080-X.CrossRefPubMed Bonaventura J, Schroeder WA, Fang S: Human erythrocyte catalase: an improved method of isolation and a re-evaluation of reported properties. Arch Biochem Biophys. 1972, 150: 606-617. 10.1016/0003-9861(72)90080-X.CrossRefPubMed
30.
go back to reference Habig WH, Pabst MJ, Jakoby WB: Glutathione S transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem. 1974, 249: 7130-7139.PubMed Habig WH, Pabst MJ, Jakoby WB: Glutathione S transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem. 1974, 249: 7130-7139.PubMed
31.
go back to reference Ellman GL: Tissue sulfhydryl group. Arch Biochem Biophys. 1959, 82: 70-77. 10.1016/0003-9861(59)90090-6.CrossRefPubMed Ellman GL: Tissue sulfhydryl group. Arch Biochem Biophys. 1959, 82: 70-77. 10.1016/0003-9861(59)90090-6.CrossRefPubMed
33.
go back to reference Reznick AZ, Packer L: Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol. 1994, 233: 357-363.CrossRefPubMed Reznick AZ, Packer L: Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol. 1994, 233: 357-363.CrossRefPubMed
34.
go back to reference Bergman I, Loxley R: Two improved and simplified methods for the spectrophotometric determination of hydroxyproline. Anal Chem. 1963, 35: 1961-1965. 10.1021/ac60205a053.CrossRef Bergman I, Loxley R: Two improved and simplified methods for the spectrophotometric determination of hydroxyproline. Anal Chem. 1963, 35: 1961-1965. 10.1021/ac60205a053.CrossRef
35.
go back to reference Kivirikko KI, Laitinen O, Prockop DJ: Modifications of a specific assay for hydroxyproline in urine. Anal Biochem. 1967, 19: 249-255. 10.1016/0003-2697(67)90160-1.CrossRefPubMed Kivirikko KI, Laitinen O, Prockop DJ: Modifications of a specific assay for hydroxyproline in urine. Anal Biochem. 1967, 19: 249-255. 10.1016/0003-2697(67)90160-1.CrossRefPubMed
36.
go back to reference Barry M, Sherlock S: Measurement of liver-iron concentration in needle biopsy specimens. Lancet. 1971, 297: 100-103. 10.1016/S0140-6736(71)90838-5.CrossRef Barry M, Sherlock S: Measurement of liver-iron concentration in needle biopsy specimens. Lancet. 1971, 297: 100-103. 10.1016/S0140-6736(71)90838-5.CrossRef
37.
go back to reference Hynes MJ, Coinceanainn M: Investigation of the release of iron from ferritin by naturally occurring antioxidants. J Inorg Biochem. 2002, 90: 18-21. 10.1016/S0162-0134(02)00383-5.CrossRefPubMed Hynes MJ, Coinceanainn M: Investigation of the release of iron from ferritin by naturally occurring antioxidants. J Inorg Biochem. 2002, 90: 18-21. 10.1016/S0162-0134(02)00383-5.CrossRefPubMed
38.
go back to reference Bonkovsky HL: Iron and the liver. Am J Med Sci. 1991, 301: 32-43. 10.1097/00000441-199101000-00006.CrossRefPubMed Bonkovsky HL: Iron and the liver. Am J Med Sci. 1991, 301: 32-43. 10.1097/00000441-199101000-00006.CrossRefPubMed
39.
go back to reference Sayre LM, Moreira PI, Smith MA, Perry G: Metal ions and oxidative protein modification in neurological disease. Ann Ist Super Sanita. 2005, 41: 143-164.PubMed Sayre LM, Moreira PI, Smith MA, Perry G: Metal ions and oxidative protein modification in neurological disease. Ann Ist Super Sanita. 2005, 41: 143-164.PubMed
40.
go back to reference Rothman RJ, Serroni A, Farber JL: Cellular pool of transient ferric iron, chelatable by deferoxamine and distinct from ferritin, that is involved in oxidative cell injury. Mol Pharmacol. 1992, 42: 703-710.PubMed Rothman RJ, Serroni A, Farber JL: Cellular pool of transient ferric iron, chelatable by deferoxamine and distinct from ferritin, that is involved in oxidative cell injury. Mol Pharmacol. 1992, 42: 703-710.PubMed
41.
go back to reference Galleano M, Simontacchi M, Puntarulo S: Nitric oxide and iron: effect of iron overload on nitric oxide production in endotoxemia. Mol Aspects Med. 2004, 25: 141-154. 10.1016/j.mam.2004.02.015.CrossRefPubMed Galleano M, Simontacchi M, Puntarulo S: Nitric oxide and iron: effect of iron overload on nitric oxide production in endotoxemia. Mol Aspects Med. 2004, 25: 141-154. 10.1016/j.mam.2004.02.015.CrossRefPubMed
42.
go back to reference Beckman KB, Ames BN: The free radical theory of aging matures. Physiol Rev. 1998, 78: 547-581.PubMed Beckman KB, Ames BN: The free radical theory of aging matures. Physiol Rev. 1998, 78: 547-581.PubMed
43.
go back to reference Bonkowsky HL, Healey JF, Sinclair PR, Sinclair JF, Pomeroy JS: Iron and the liver. Acute and long-term effects of iron-loading on hepatic haem metabolism. Biochem J. 1981, 196: 57-64.CrossRefPubMedPubMedCentral Bonkowsky HL, Healey JF, Sinclair PR, Sinclair JF, Pomeroy JS: Iron and the liver. Acute and long-term effects of iron-loading on hepatic haem metabolism. Biochem J. 1981, 196: 57-64.CrossRefPubMedPubMedCentral
44.
go back to reference Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R: Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta. 2003, 329: 23-28. 10.1016/S0009-8981(03)00003-2.CrossRefPubMed Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R: Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta. 2003, 329: 23-28. 10.1016/S0009-8981(03)00003-2.CrossRefPubMed
45.
go back to reference Ramm GA, Ruddell RG: Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis. Semin Liver Dis. 2005, 25: 433-449. 10.1055/s-2005-923315.CrossRefPubMed Ramm GA, Ruddell RG: Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis. Semin Liver Dis. 2005, 25: 433-449. 10.1055/s-2005-923315.CrossRefPubMed
46.
go back to reference Harrison PM: Ferritin: an iron-storage molecule. Sem Hematol. 1977, 14: 55-70. Harrison PM: Ferritin: an iron-storage molecule. Sem Hematol. 1977, 14: 55-70.
47.
go back to reference O'Brien RT: Ascorbic acid enhancement of desferrioxamine-induced urinary iron excretion in thalassemia major. Ann NY Acad Sci. 1974, 232: 221-225. 10.1111/j.1749-6632.1974.tb20588.x.CrossRefPubMed O'Brien RT: Ascorbic acid enhancement of desferrioxamine-induced urinary iron excretion in thalassemia major. Ann NY Acad Sci. 1974, 232: 221-225. 10.1111/j.1749-6632.1974.tb20588.x.CrossRefPubMed
Metadata
Title
Reducing power and iron chelating property of Terminalia chebula (Retz.) alleviates iron induced liver toxicity in mice
Authors
Rhitajit Sarkar
Bibhabasu Hazra
Nripendranath Mandal
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2012
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/1472-6882-12-144

Other articles of this Issue 1/2012

BMC Complementary Medicine and Therapies 1/2012 Go to the issue